Nathan Phelps, MD | |
4650 Harrison Blvd, Ogden, UT 84403-4303 | |
(801) 475-3021 | |
(801) 475-3031 |
Full Name | Nathan Phelps |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 4650 Harrison Blvd, Ogden, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255628996 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 9140789-1205 (Utah) | Primary |
Entity Name | Joshua Oaks |
---|---|
Entity Type | Practitioner - Internal Medicine |
Entity Identifiers | NPI Number: 1205221405 PECOS PAC ID: 0244594729 Enrollment ID: I20180509001485 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the launch of ABLAVARâ„¢ (gadofosveset trisodium), a unique, injectable MRA imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).
One of the most important questions about complementary medicine - does it generate more harm than good - remains unanswered because two alternative and antagonistic attitudes are influencing the evidence, says an expert today.
As part of their effort to find funds for universal health coverage, Democrats have targeted federal subsidies for Medicare's private plans.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
The development of a new method to grow three-dimensional organoid cultures of pancreatic tumors directly from patients' surgical tissue offers a promising opportunity for testing targeted therapies and drug responses and personalizing treatments in a rapid, cost-effective manner.
› Verified 1 days ago
Entity Name | Ogden Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578550083 PECOS PAC ID: 9638078033 Enrollment ID: O20040105000780 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the launch of ABLAVARâ„¢ (gadofosveset trisodium), a unique, injectable MRA imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).
One of the most important questions about complementary medicine - does it generate more harm than good - remains unanswered because two alternative and antagonistic attitudes are influencing the evidence, says an expert today.
As part of their effort to find funds for universal health coverage, Democrats have targeted federal subsidies for Medicare's private plans.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
The development of a new method to grow three-dimensional organoid cultures of pancreatic tumors directly from patients' surgical tissue offers a promising opportunity for testing targeted therapies and drug responses and personalizing treatments in a rapid, cost-effective manner.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Nathan Phelps, MD Po Box 5546, Denver, CO 80217-5546 Ph: (801) 475-3021 | Nathan Phelps, MD 4650 Harrison Blvd, Ogden, UT 84403-4303 Ph: (801) 475-3021 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the launch of ABLAVARâ„¢ (gadofosveset trisodium), a unique, injectable MRA imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).
One of the most important questions about complementary medicine - does it generate more harm than good - remains unanswered because two alternative and antagonistic attitudes are influencing the evidence, says an expert today.
As part of their effort to find funds for universal health coverage, Democrats have targeted federal subsidies for Medicare's private plans.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
The development of a new method to grow three-dimensional organoid cultures of pancreatic tumors directly from patients' surgical tissue offers a promising opportunity for testing targeted therapies and drug responses and personalizing treatments in a rapid, cost-effective manner.
› Verified 1 days ago
Scott Allen Andelin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd, Ste A-700, Ogden, UT 84403 Phone: 801-387-5300 | |
John M Hemmersmeier, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5740 Crestwood Dr, Ogden, UT 84405 Phone: 801-479-7771 Fax: 801-479-7795 | |
Kristine M Oates, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4403 Harrison Blvd, Ste. A700, Ogden, UT 84403 Phone: 801-387-5300 Fax: 801-387-5335 | |
Benjamin Zachary Larsen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd Ste 700a, Ogden, UT 84403 Phone: 801-387-5300 Fax: 801-387-5333 | |
Robert L Adams, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1355 Hinkley Dr, Ogden, UT 84401 Phone: 801-387-6050 | |
Mary Ellen Mason, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4650 Harrison Blvd, Ogden, UT 84403 Phone: 801-475-3010 Fax: 801-475-3001 | |
Brett Wayne Martindale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Harrison Blvd, Ogden, UT 84403 Phone: 801-475-3300 Fax: 801-475-3301 |